Germline RAD51C mutations confer susceptibility to ovarian cancer

[1]  D. Easton,et al.  Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations , 2012, Genetic epidemiology.

[2]  Samantha E. Boyle,et al.  Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients , 2012, Hereditary Cancer in Clinical Practice.

[3]  Susan L. Neuhausen,et al.  RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families , 2011, PloS one.

[4]  Deborah Hughes,et al.  Germline mutations in RAD51D confer susceptibility to ovarian cancer , 2011, Nature Genetics.

[5]  J. Schleutker,et al.  RAD51C is a susceptibility gene for ovarian cancer. , 2011, Human molecular genetics.

[6]  A. Mannermaa,et al.  Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility , 2011, Breast Cancer Research and Treatment.

[7]  Yuntao Xie,et al.  RAD51C germline mutations in Chinese women with familial breast cancer , 2011, Breast Cancer Research and Treatment.

[8]  P. Pérez-Segura,et al.  A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families , 2011, Breast Cancer Research and Treatment.

[9]  R. Scott,et al.  BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer , 2011, Breast Cancer Research and Treatment.

[10]  D. Palli,et al.  Mutation screening of RAD51C in male breast cancer patients , 2011, Breast Cancer Research.

[11]  Marc Tischkowitz,et al.  RAD51C germline mutations in breast and ovarian cancer patients , 2010, Breast Cancer Research.

[12]  Jing Zhang,et al.  Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer , 2010, Breast Cancer Research and Treatment.

[13]  E. Levy-Lahad,et al.  Fanconi anemia and breast cancer susceptibility meet again , 2010, Nature Genetics.

[14]  Dieter Niederacher,et al.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene , 2010, Nature Genetics.

[15]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[16]  Nazneen Rahman,et al.  Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles , 2006, Nature Genetics.

[17]  N. Rahman,et al.  ATM and breast cancer susceptibility , 2006, Oncogene.

[18]  D. Easton,et al.  EMGM Abstracts , 2003, Genetic epidemiology.

[19]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[20]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[21]  N E Day,et al.  Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.

[22]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[23]  S. Karlin,et al.  Prediction of complete gene structures in human genomic DNA. , 1997, Journal of molecular biology.

[24]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[25]  S. Knudsen,et al.  Prediction of human mRNA donor and acceptor sites from the DNA sequence. , 1991, Journal of molecular biology.

[26]  Cancer incidence in five continents. Volume VIII. , 2002, IARC scientific publications.

[27]  K. Lange,et al.  Programs for pedigree analysis: Mendel, Fisher, and dGene , 1988, Genetic epidemiology.